CSF3 and acute myeloid leukemia: Therefore, this result confirms our previous report that patients whose AML cells demonstrated robust STAT3 activation in response to G-CSF and IL-6 stimulation had a significantly better outcome than patients whose blasts did not respond to these stimuli [14].